Zurcher Kantonalbank (Zurich Cantonalbank) Eye Point Pharmaceuticals, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 13,895 shares of EYPT stock, worth $86,010. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,895
Previous 10,874
27.78%
Holding current value
$86,010
Previous $86,000
19.77%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$51.5 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$42 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$35.6 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$25.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$23.5 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $211M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...